Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002952726 | SCV003270766 | uncertain significance | not provided | 2023-08-16 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 2059300). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with MCM5-related conditions. This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 28 of the MCM5 protein (p.Lys28Thr). This variant is present in population databases (rs200623346, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. |
Ambry Genetics | RCV004067185 | SCV004902980 | uncertain significance | not specified | 2023-11-28 | criteria provided, single submitter | clinical testing | The c.83A>C (p.K28T) alteration is located in exon 2 (coding exon 1) of the MCM5 gene. This alteration results from a A to C substitution at nucleotide position 83, causing the lysine (K) at amino acid position 28 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |